Jasper Therapeutics, Inc. (JSPR) Reports In-Line Q2 EPS

Jasper Therapeutics, Inc. (NASDAQ: JSPR) reported Q2 EPS of ($0.15), in-line with the analyst estimate of ($0.15).

For earnings history and earnings-related data on Jasper Therapeutics, Inc. (JSPR) click here.

You May Also Be Interested In

• Wolverine World Wide (WWW) Tops Q2 EPS by 2c; offers guidance
• Cheniere Energy (LNG) PT Raised to $300 at Mizuho
• Salem Media Group (SALM) Reports Q2 Loss of $0.11